文献速递其他结缔组织病

系统性硬化症影像学进展

Advances in imaging for systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本文为叙述性综述,旨在概述可用于区分系统性硬化症(SSc)器官层面活动性(早期炎症与早期纤维化)与损伤(晚期不可逆固定血管病变或纤维化)的现有及新兴影像工具,重点关注早期纤维化与炎症表现。

要点

  • SSc个体死亡率居风湿病首位,器官纤维化是 irreversible 损伤主因,早期炎症仍可应答免疫调节治疗。
  • 肺超声及改进的滑膜超声评估等新兴应用有助于客观区分活动性与损伤。
  • 区分活动性与损伤对优化SSc治疗时间窗至关重要。

核心结论

  • 现有及新兴影像工具可能有助于在SSc器官层面区分活动性(早期炎症与早期纤维化)与损伤(晚期不可逆固定血管病变或纤维化)。

研究设计与样本

  • 叙述性综述,旨在提供SSc中可用于区分活动性与损伤的现有及新兴影像工具的更新概述,重点关注早期纤维化与炎症表现。

主要发现

  • SSc是个体死亡率最高的风湿病,并伴随显著影响生活质量的发病率。
  • 器官纤维化是SSc不可逆损伤的主要贡献因素,而早期炎症表现 largely 反映疾病活动性并可能仍对早期免疫调节治疗有应答。
  • 肺超声或改进的滑膜超声评估等新影像模态及既定技术的新应用,为在器官层面客观区分活动性与损伤提供了有希望的机会。

临床怎么用

  • 在SSc器官评估中可考虑应用现有及新兴影像工具,以辅助区分早期炎症/早期纤维化(活动性)与晚期不可逆固定血管病变/纤维化(损伤),从而优化治疗时间窗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SSc is the rheumatic disease with the highest individual mortality rate and is associated with substantial morbidity that severely affects quality of life. Organ fibrosis is a major contributor to irreversible damage in SSc, whereas early inflammatory manifestations largely reflect disease activity and may still respond to early immunomodulatory treatment. New imaging modalities, as well as novel applications of established techniques-such as lung US or improved US assessment of synovial involvement-offer promising opportunities to objectively distinguish activity i.e. early inflammation and early fibrosis from damage (i.e. late irreversible fixed vasculopathy or fibrosis) at the organ level. Differentiating these processes is essential for refining the therapeutic window of opportunity in this rare but devastating disease. This narrative review aims to provide an up-to-date overview of available and emerging imaging tools that may help discriminate activity from damage across organ systems involved in SSc, with a specific focus on early fibrotic and inflammatory manifestations.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lescoat A, Ross L, Bergmann C, et al. Advances in imaging for systemic sclerosis. Rheumatology (Oxford). 2026. PMID: 42697691. doi:10.1093/rheumatology/keag390

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。